It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Shares of GSK plc (LON:GSK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One research ...

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...

GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan ...

GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract infections (uUTIs) in female adults and adolescents. A commercial launch ...

That involved working with GSK’s R&D, supply chain, and commercial units, to use data in a way that made sense for the company. Ramakrishnan says the company was an “early thinker” in ...

(GSK, GSK.L) announced that the US Food and Drug ... Staphylococcus saprophyticus and Enterococcus faecalis. US commercial launch is planned in the second-half of 2025. Uncomplicated urinary ...